Neal Franklin Fowler
CIK: 0001493692
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EBS
Emergent BioSolutions Inc.
Director
Discretionary Trading P&L
Holdings
About Fowler Neal Franklin
Fowler Neal Franklin (SEC CIK 0001493692) files insider reports with the SEC as Director of Emergent BioSolutions Inc. (EBS).
Signal8 holds 3 ownership filings by Fowler Neal Franklin, all Form 4s, filed between Mar 12, 2025 and May 4, 2026. Those filings report 3 transactions, from Mar 12, 2025 to Apr 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Fowler Neal Franklin's filings is in GAITHERSBURG, MD.
Recent filings by Fowler Neal Franklin
Other insiders filing for Emergent BioSolutions Inc. (EBS)
- DeGolyer Donald W, Director
- Williams Paul Anthony, SVP, Products Business
- Duatschek Stephanie, EVP, CGO
- LINDAHL RICHARD S, EVP, Chief Financial Officer
- Glessner Coleen, EVP, Quality & Ethics, and CPL
- Hartzel William, SVP, Bioservices